Replimune Group

REPL · NASDAQ

$11.42+$0.37 (+3.35%)TodayMarket closed ·
Prev close $11.05

Latest news

  • Press releaseGlobe Newswire

    Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 5, 2026 in Replimune Group, Inc. Lawsuit - REPL

  • Press releaseGlobe Newswire

    Replimune Announces TUDRIQEV™ Now Available in the U.S. for Advanced Melanoma

  • Press releasePRNewswire

    SueWallSt Reminds Replimune Group, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of October 5, 2026 - REPL

  • Press releasePRNewswire

    REPL Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Replimune Group, Inc. Securities Lawsuit - Contact Levi & Korsinsky

  • Press releaseGlobe Newswire

    REPLIMUNE CLASS ACTION DEADLINE MONDAY: Bragar Eagel & Squire, P.C. Urgently Reminds Replimune Group Inc. Investors to Contact the Firm Seeking Lead Plaintiff Role Before October 5th

  • Press releaseNewsfile

    Robbins LLP is Investigating Allegations that Replimune Group, Inc. Misled Investors Regarding the Efficacy and Viability of its Lead Product Candidate RP1

  • Press releaseGlobe Newswire

    REPL Investor Alert: Replimune Group, Inc. Securities Class Action Notice - Contact Levi & Korsinsky

  • Press releasePRNewswire

    INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Replimune Group, Inc. of Class Action Lawsuit and Upcoming Deadlines - REPL

  • Press releasePRNewswire

    REPL Deadline Alert: SueWallSt Reminds Replimune Group, Inc. (REPL) Investors of Securities Class Action Deadline on October 5, 2026

  • Press releasePRNewswire

    REPL UPCOMING DEADLINE: Levi & Korsinsky Alerts Replimune Group, Inc. Stockholders of Securities Class Action - Contact the Firm

  • Press releaseGlobe Newswire

    Portnoy Law Firm Announces Class Action on Behalf of Replimune Group, Inc. Investors

  • Press releasePRNewswire

    REPL Stockholders with Significant Losses Should Contact Robbins LLP Before the Pending October 5, 2026 Lead Plaintiff Deadline for Information About Recovering Their Losses

  • Press releasePRNewswire

    REPL Shareholder Alert: Replimune Group, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact SueWallSt

  • Press releasePRNewswire

    INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Replimune Group, Inc. of Class Action Lawsuit and Upcoming Deadlines - REPL

  • Press releasePRNewswire

    Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 5, 2026 in Replimune Group, Inc. Lawsuit - REPL

  • Press releaseGlobe Newswire

    INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Replimune Group, Inc. of Class Action Lawsuit and Upcoming Deadlines – REPL

  • Press releaseGlobe Newswire

    Portnoy Law Firm Announces Class Action on Behalf of Replimune Group, Inc. Investors

  • Press releaseGlobe Newswire

    REPL Stock Drop - Robbins LLP Reminds Investors They May Be Eligible to Lead the Class Action Lawsuit Against Replimune Group, Inc.

  • Press releaseGlobe Newswire

    Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Replimune Group Inc. and Encourages Investors to Contact the Firm

  • Press releaseBusiness Wire

    REPL Shareholder Alert: October 5, 2026 Lead Plaintiff Deadline in Replimune Group, Inc. Securities Class Action - Contact Levi & Korsinsky

  • Press releasePRNewswire

    REPL Investor Alert: Replimune Group, Inc. Securities Class Action Notice - Contact SueWallSt

  • Press releasePRNewswire

    INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Replimune Group, Inc. of Class Action Lawsuit and Upcoming Deadlines - REPL

  • Press releasePRNewswire

    REPL Deadline Alert: Levi & Korsinsky Reminds Replimune Group, Inc. (REPL) Investors of Securities Class Action Deadline on October 5, 2026

  • Press releasePRNewswire

    REPL DEADLINE: SueWallSt Reminds Replimune Group, Inc. Investors of Upcoming Securities Class Action Deadline

  • Press releaseBusiness Wire

    Robbins LLP Urges REPL Stockholders to Contact the Firm for Information About the Class Action Against Replimune Group, Inc.

  • Press releasePRNewswire

    REPL Shareholder Alert: Replimune Group, Inc. Securities Class Action Lawsuit - Investors With Losses May Contact Levi & Korsinsky

  • Press releaseGlobe Newswire

    Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Replimune Group Inc. and Encourages Investors to Contact the Firm

  • Press releasePRNewswire

    INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Replimune Group, Inc. of Class Action Lawsuit and Upcoming Deadlines - REPL

  • NewsVandana Singh

    Two Rejections, Messy Process: Replimune Finally Secures FDA Approval for Skin Cancer Treatment

  • News

    12 Health Care Stocks Moving In Friday's Intraday Session

  • NewsVandana Singh

    Replimune Skin Cancer Therapy Hopes Revive After Positive FDA Panel Vote

  • NewsAvi Kapoor

    Nasdaq Surges 300 Points; Amazon Shares Jump Following Upbeat Earnings

  • News

    12 Health Care Stocks Moving In Friday's Pre-Market Session

  • News

    Market-Moving News for July 31st

  • News

    12 Health Care Stocks Moving In Tuesday's Intraday Session

  • News

    12 Health Care Stocks Moving In Tuesday's Pre-Market Session

  • News

    12 Health Care Stocks Moving In Thursday's After-Market Session

  • NewsAvi Kapoor

    Optimum Communications, Fluence Energy, Virgin Galactic And Other Big Stocks Moving Higher Today

  • NewsVandana Singh

    Why Is Replimune Stock Gaining Monday?

  • NewsPiero Cingari

    Micron Rallied 90% In A Month — These 10 Small‑Cap Stocks Blew Past It

  • NewsAvi Kapoor

    Kimberly-Clark, Vertex And Other Big Stocks Moving Lower In Monday's Pre-Market Session

  • NewsAvi Kapoor

    Dow Jumps Over 200 Points; Cleveland-Cliffs Shares Jump After Q3 Results

  • NewsAvi Kapoor

    Gold Falls Over 1%; Darden Posts Downbeat Earnings

  • NewsAvi Kapoor

    Nasdaq Surges 100 Points; Bionano Genomics Shares Plunge

  • NewsAvi Kapoor

    Why KULR Technology Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket

  • NewsChris Katje

    EXCLUSIVE: July's 20 Most-Searched Tickers On Benzinga Pro — Where Do Opendoor, Nvidia, Apple Stock Rank?

  • NewsAvi Kapoor

    Why Meta Platforms Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket

  • NewsAvi Kapoor

    US Stocks Edge Higher; Kraft Heinz Earnings Top Views

  • NewsAvi Kapoor

    This Centene Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday

  • NewsAvi Kapoor

    Nasdaq Falls Over 100 Points; Coca-Cola Posts Upbeat Earnings

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.